Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Health

Researchers unveil a potentially new effective treatment for diabetic retinopathy

Staff Writer
Staff Writer 1 year ago
Updated 2021/05/12 at 6:20 PM
Share
SHARE

The French-based Université de Montréal released a new report in the journal Cell Metabolism highlighting the potential for a new treatment to effectively treat diabetic retinopathy.

The drug treatment is, at the moment of this publication, the subject of phase 1 human studies in Canada.

The potential for the experimental treatment to destroy groups of cells known to result in diabetic eye disease became a central focus for researchers.

A molecular target known as BCL-xL is the primary focus of the study, as researchers aimed at identifying defective retinal blood vessels, which points to disease.

The drug treatment utilizes the molecular target to aid in the retina’s self-repairing of the defective vessels, thus improving diabetic eye disease.

“I am proud of our leadership in vision health in both the clinical and scientific communities,” said Sylvain Lemieux of CIUSSS de l’Est-de-l’Île-de-Montréal, in a news release.

“Once again, the results of the work of researchers at MRH-RC are very promising for the quality of life of people with ocular diseases.”

Photo: BMA

You Might Also Like

New research of vegetarian diets uncovered similar growth and nutrition as meat consumers

Being overweight during childhood may raise the risk of type 1 diabetes

Over a million less smokers projected after U.S. ban on menthol cigarettes: study

Study probes the communication between physicians and patients regarding e-cigarette use

Nearly one-third of breast cancer patients experience depressive symptoms

TAGGED: BCL-xL, diabetic retinopathy
Staff Writer February 14, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article How small and medium-sized firms apply social media in their sales processes
Next Article The risk of childhood asthma may be heightened by fetal exposure to antibiotics in mid to late pregnancy

Recommended

Health

New research of vegetarian diets uncovered similar growth and nutrition as meat consumers

1 Min Read
Health

Being overweight during childhood may raise the risk of type 1 diabetes

1 Min Read
Health

Over a million less smokers projected after U.S. ban on menthol cigarettes: study

1 Min Read
Health

Study probes the communication between physicians and patients regarding e-cigarette use

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?